Sebetralstat: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Sebetralstat. Educational only — not medical advice.
Labeled uses
EKTERLY® is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.
Source: FDA labeling via NIH DailyMed (set 1d145e2f…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.